Learn about the epidemiology, clinical presentation, treatment and long-term outcomes of infants with neonatal abstinence syndrome (NAS) in the U.S. Opportunities for prevention and early intervention will be discussed.
Speakers:
Margaret (Peggy) Honein, PhD, MPH
Director, Division of Congenital and Developmental Disorders, Centers for Disease Control and Prevention
Mary-Margaret A. Fill, MD
Medical Epidemiologist, Tennessee Department of Health
Michael Warren, MD, MPH, FAAP
Associate Administrator, Maternal and Child Health Bureau, Health Resources and Services Administration
Rebecca Russell, MSPH
(Moderator), SVP (Interim) Science and Strategy Senior Director, Applied Research and Evaluation, March of Dimes
Session Goals:
Learn about the epidemiology, clinical presentation, treatment and long-term outcomes of infants with neonatal abstinence syndrome (NAS) in the U.S. Opportunities for prevention and early intervention will be discussed.
Learning Objectives:
1. Discuss CDC’s role in protecting mothers and babies in the context of the opioid epidemic.
2. Review the clinical presentation and treatment options for infants with Neonatal Abstinence Syndrome.
3. Discuss possible long-term outcomes of Neonatal Abstinence Syndrome.
4. Outline opportunities for prevention or early intervention in children and families at risk for Neonatal Abstinence Syndrome.
A live webcast sponsored by:
March of Dimes and Clinical Directors Network, Inc. (CDN)
Date:
Monday, October 29, 2018 from 2:30 PM to 3:30 PM EDT
Slideset:
Long-Term Outcomes of Neonatal Abstinence Syndrome: Implications for Providers and Caregivers (PDF)
Suggested Links:
Infographic: “Preventing NAS in your baby” (marchofdimes.org)
Infographic: “Caring for a baby with NAS” (marchofdimes.org)
Evaluations for CME/CNE Credits:
This webcast is approved for up to 1.0 Prescribed CME credits by the American Academy of Family Physicians (AAFP) and 1.0 prescribed CNE credits by American Nurses Credentialing Center (ANCC).
